Related Experiment Video
Updated: Jun 12, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
The difference between rare and exceptionally rare: molecular characterization of ribose 5-phosphate isomerase
Mirjam M C Wamelink1, Nana-Maria Grüning, Erwin E W Jansen
1Department of Clinical Chemistry, VU University Medical Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
Abstract:
Ribose 5-phosphate isomerase (RPI) deficiency is an enzymopathy of the pentose phosphate pathway. It manifests with progressive leukoencephalopathy and peripheral neuropathy and belongs, with one sole diagnosed case, to the rarest human disorders. The single patient was found compound heterozygous for a RPI frameshift and a missense (RPI(Ala61Val)) allele. Here, we report that two patient-derived cell lines differ in RPI enzyme activity, enzyme concentration, and mRNA expression. Furthermore, we present a transgenic yeast model, which exhibits metabolite- and enzyme-activity changes that correspond to the human syndrome and show that the decrease in RPI activity in patient cells is not fully attributable to the residue exchange. Taken together, our results demonstrate that RPI deficiency is caused by the combination of a RPI null allele with an allele that encodes for a partially active enzyme which has, in addition, cell-type-dependent expression deficits. We speculate that a low probability for comparable traits accounts for the rareness of RPI deficiency.
Insights
Ribose 5-phosphate isomerase (RPI) deficiency, a rare disorder causing leukoencephalopathy, results from a combination of a non-functional RPI allele and a partially active one with expression deficits. This study clarifies the molecular basis of this rare genetic condition.
Area of Science:
- Biochemistry
- Genetics
- Neuroscience
Background:
- Ribose 5-phosphate isomerase (RPI) deficiency is an extremely rare enzymopathy of the pentose phosphate pathway.
- It is characterized by progressive leukoencephalopathy and peripheral neuropathy.
Purpose of the Study:
- To investigate the molecular mechanisms underlying RPI deficiency.
- To characterize patient-derived cell lines and develop a relevant model system.
Main Methods:
- Analysis of patient-derived cell lines for RPI enzyme activity, concentration, and mRNA expression.
- Development of a transgenic yeast model to study RPI deficiency.
- Genetic analysis of patient alleles.
Main Results:
- Patient-derived cell lines exhibited varying RPI enzyme activity, concentration, and mRNA expression.
- The transgenic yeast model recapitulated metabolic and enzyme activity changes observed in the human syndrome.
- Reduced RPI activity in patient cells was not solely due to the missense mutation (RPI(Ala61Val)).
- RPI deficiency results from a null allele combined with a partially active allele exhibiting cell-type-dependent expression deficits.
Conclusions:
- RPI deficiency is caused by compound heterozygosity for a null RPI allele and a hypomorphic allele with expression issues.
- The complexity of these genetic and expression factors likely contributes to the extreme rarity of RPI deficiency.
Related Concept Videos
Ribozymes
Ribozymes can be...
Ribozymes
Ribozymes can be...
Riboswitches
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
Inborn Errors of Metabolism
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
Incomplete Dominance

